Latest News in the pharma Industry

All

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

1 Sep 2020

Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world’s largest vaccine ma...

Read more 
Aragen Bioscience announces the appointment of Steven Lang, PHD, MBA as Vice President, Biologics

Aragen Bioscience announces the appointment of Steven Lang, PHD, MBA as Vice President, Biologics

1 Sep 2020

Aragen Bioscience is pleased to announce the appointment of Dr. Steven Lang as Vice President, Biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologics product development wi...

Read more 
Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia

Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia

1 Sep 2020

Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D i...

Read more 
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process

Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process

1 Sep 2020

Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances

Read more 
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate

Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate

1 Sep 2020

Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused o...

Read more 
KORSCH introduces next-generation mid-range tablet press

KORSCH introduces next-generation mid-range tablet press

1 Sep 2020

X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines.

Read more 
Development of rapid novel SARS-CoV-2 diagnostics started

Development of rapid novel SARS-CoV-2 diagnostics started

1 Sep 2020

Enzyme specialists from EUCODIS Bioscience and diagnostics experts from Biosynth-Carbosynth have teamed up to develop a novel diagnostic tool for the fast and reliable detection of an acute SARS-CoV-2 infection. Based on viral enzymatic activities and ...

Read more 
Vaccine Testing to Ensure Successful and Faster Vaccine Research and Development

Vaccine Testing to Ensure Successful and Faster Vaccine Research and Development

1 Sep 2020

Following its emergence earlier this year, the novel coronavirus (SARS-CoV-2) has spread rapidly and snowballed into a pandemic. Everyone – citizens, businesses, and governments – yearns for life to go back to normal soon.

Read more 
Managing Your Life Sciences Quality Management System Remotely

Managing Your Life Sciences Quality Management System Remotely

1 Sep 2020

Telecommuting and online commerce has been with us for some time and works seamlessly in many industries, but the current state of events has forced companies to apply remote management to other areas that have historically been considered "hands-on" j...

Read more 
SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate

SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate

1 Sep 2020

SGS is pleased to announce the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its sp...

Read more 
SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine

SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine

1 Sep 2020

In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov...

Read more 
Mylan and Biocon Biologics launch Lantus biosimilar in the US

Mylan and Biocon Biologics launch Lantus biosimilar in the US

1 Sep 2020

Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market.

Read more